Getting an Accurate Diagnosis: Tests and Results
At a Glance
A diagnosis of vulvovaginal candidiasis should combine symptoms with an exam and laboratory testing. A negative microscope test may miss infection; culture or molecular testing can identify Candida, but symptoms help show whether it is causing the problem.
Getting an accurate diagnosis for vulvovaginal candidiasis (VVC) is more complex than simply checking for itching or discharge. Because many vaginal conditions share the same symptoms, clinical guidelines emphasize that a diagnosis should be based on a combination of your symptoms and specific laboratory tests, rather than a physical exam alone [1][2].
The Step-by-Step Diagnostic Process
When you see a healthcare provider for vaginal symptoms, you can expect a structured evaluation designed to pinpoint the exact cause of your discomfort.
- Clinical History and Pelvic Exam: Your doctor will ask about your symptoms and perform a physical exam. A pelvic exam allows the provider to look for signs of inflammation and to assess for signs of other conditions, including Pelvic Inflammatory Disease (PID)—an infection of the upper reproductive tract [3][4]. Note: A normal pelvic exam does not completely rule out PID. If you have fever, lower-abdominal or pelvic pain, foul-smelling discharge, or abnormal bleeding, seek prompt care.
- Vaginal pH Testing: A small sample of fluid is tested for acidity. In a typical yeast infection, the pH remains at or below 4.5 (normal acidity). If the pH is higher, it suggests other conditions like bacterial vaginosis or trichomoniasis [2][5].
- Wet Mount and KOH Microscopy: This is the most common immediate test. A sample of discharge is placed on a slide with a saline or potassium hydroxide (KOH) solution and viewed under a microscope. The goal is to see budding yeast or pseudohyphae (the branch-like structures yeast forms) [2][1].
Why Microscopy Isn’t Always Enough
While microscopy is fast, it is not perfectly accurate. In some studies, the sensitivity (the ability of a test to correctly identify those with the disease) of a wet mount was only about 48.5% [6]. This means that more than half of the time, the microscope may miss a yeast infection even when it is present [6].
A negative microscopy result does not reliably exclude VVC if your symptoms are still present. If the microscope shows nothing but you are still in pain, your doctor should move on to more sensitive testing [2].
Fungal Culture: The Gold Standard
A fungal culture is considered the “gold standard” for diagnosing yeast infections. A sample is sent to a lab to see if yeast grows over several days [2]. Culture is essential for complicated VVC—which includes infections that are severe, recurrent, or happening in people with weakened immune systems [7].
The primary advantage of a culture is speciation: it identifies exactly which type of Candida is present. This is vital because non-albicans species, such as Candida glabrata, often require different medications than the standard treatments used for Candida albicans [8][9].
Molecular Testing (NAAT)
Newer molecular tests, known as Nucleic Acid Amplification Tests (NAAT), look for the DNA of the yeast. The sensitivity of these tests varies by the specific assay used, but they are often highly sensitive—sometimes detecting yeast in 92% of cases compared to 83% for culture in specific studies [6].
However, these tests must be interpreted carefully. Because 20% to 30% of healthy women carry Candida without any symptoms, a positive DNA test or culture only confirms the yeast is present; it doesn’t prove the yeast is the cause of your symptoms [10][11][12].
Important: Colonization Is Not Infection
It is a key medical principle that asymptomatic colonization—when yeast is present but you feel fine—should not be treated [1][2].
Treating yeast when you have no symptoms provides no benefit and can lead to:
- Unnecessary side effects from medication.
- Increased risk of the yeast developing resistance to antifungal drugs [13].
- Disruption of the healthy bacteria (lactobacilli) that protect the vaginal environment [14].
Susceptibility Testing for Persistent Cases
If your infection is recurrent or fails to respond to treatment, and a culture has confirmed the species, your doctor may order antifungal susceptibility testing [8]. This laboratory test determines which specific drugs (like fluconazole or miconazole) are most effective at killing the particular strain of yeast you have, proving whether or not it is truly resistant [15]. While this is not needed for most simple infections, it is a powerful tool for managing chronic or resistant cases [8][16].
Premenstrual Flares
If your symptoms consistently flare up just before your period, it could be a true cyclic yeast infection, but it could also be cyclic vulvovaginitis or a skin condition like dermatitis. Arrange for testing during an active flare, ideally before applying any over-the-counter creams, to confirm exactly what is happening.
Common questions in this guide
How is vulvovaginal candidiasis diagnosed?
Can a negative wet mount rule out a vaginal yeast infection?
What does a vaginal pH of 4.5 or lower mean?
Does a positive Candida culture or NAAT prove I have a yeast infection?
Why do Candida species and susceptibility results matter?
How should I prepare for testing if symptoms flare before my period?
What symptoms need prompt medical evaluation instead of routine yeast testing?
One line in your results can change your plan.
A negative microscope result does not reliably rule out a yeast infection if symptoms persist, so your doctor should move on to more sensitive testing. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on vulvovaginal candidiasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, et al.
Mycoses 2021; (64(6)):583-602 doi:10.1111/myc.13248.
PMID: 33529414 - 2
Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
Nyirjesy P, Brookhart C, Lazenby G, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (74(Suppl_2)):S162-S168 doi:10.1093/cid/ciab1057.
PMID: 35416967 - 3
Infectious Vaginitis, Cervicitis, and Pelvic Inflammatory Disease.
Shroff S
The Medical clinics of North America 2023; (107(2)):299-315 doi:10.1016/j.mcna.2022.10.009.
PMID: 36759099 - 4
Clinical utility of nucleic acid amplification testing for detection of sexually transmitted infections in women with symptomatic bacterial vaginosis and vulvovaginal candidiasis identified by conventional versus molecular diagnoses.
Getman D, Seña AC, Nenninger A, Schwebke JR
Journal of clinical microbiology 2026; (64(9)):e0011726 doi:10.1128/jcm.00117-26.
PMID: 42626953 - 5
Clinical Evaluation of a Self-Testing Kit for Vaginal Infection Diagnosis.
Shen CJ, Yang CY, Chen HY, et al.
Journal of healthcare engineering 2021; (2021()):4948954 doi:10.1155/2021/4948954.
PMID: 34394891 - 6
Nucleic Acid Amplification Testing Compared With Cultures, Gram Stain, and Microscopy in the Diagnosis of Vaginitis.
Danby CS, Althouse AD, Hillier SL, Wiesenfeld HC
Journal of lower genital tract disease 2021; (25(1)):76-80 doi:10.1097/LGT.0000000000000576.
PMID: 33347046 - 7
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations.
Day T, Sobel JD
Clinical microbiology reviews 2025; (38(2)):e0002025 doi:10.1128/cmr.00020-25.
PMID: 40434101 - 8
Non-albicans Candida and rare yeasts in vulvovaginal candidiasis: pathogen attribution, antifungal resistance, persistence, and species-informed management.
Yan Z, Cui Y, Li Y, et al.
Frontiers in microbiology 2026; (17()):1944046 doi:10.3389/fmicb.2026.1944046.
PMID: 42780976 - 9
Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.
Dunaiski CM, Kock MM, Chan WY, et al.
Medical mycology 2024; (62(2)) doi:10.1093/mmy/myae009.
PMID: 38308518 - 10
Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome.
Farr A, Kiss H, Holzer I, et al.
Acta obstetricia et gynecologica Scandinavica 2015; (94(9)):989-96 doi:10.1111/aogs.12697.
PMID: 26084843 - 11
Detection of Candida spp. in the vagina of a cohort of nulliparous pregnant women by culture and molecular methods: Is there an association between maternal vaginal and infant oral colonisation?
Payne MS, Cullinane M, Garland SM, et al.
The Australian & New Zealand journal of obstetrics & gynaecology 2016; (56(2)):179-84 doi:10.1111/ajo.12409.
PMID: 26437337 - 12
Quantitative system for diagnosis of vulvovaginal candidiasis.
Dermendzhiev T, Pehlivanov B, Petrova A, et al.
Journal de mycologie medicale 2022; (32(4)):101302 doi:10.1016/j.mycmed.2022.101302.
PMID: 35717682 - 13
Rapid Molecular Diagnostics in Vulvovaginal Candidosis.
Akinosoglou K, Schinas G, Papageorgiou D, et al.
Diagnostics (Basel, Switzerland) 2024; (14(20)) doi:10.3390/diagnostics14202313.
PMID: 39451635 - 14
Cytolytic Vaginosis in Women with Vaginitis: Prevalence, Diagnosis, and Treatment.
Kömeç S, Tercan C, Ceylan AN, et al.
Gynecologic and obstetric investigation 2026; (91(3)):305-311 doi:10.1159/000548768.
PMID: 41045474 - 15
Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis.
Kroustali V, Kanioura L, Resoulai E, et al.
Microbiology spectrum 2025; (13(3)):e0248824 doi:10.1128/spectrum.02488-24.
PMID: 39846759 - 16
Determining Susceptibility in Candida Vaginal Isolates.
Sobel JD, Akins R
Antimicrobial agents and chemotherapy 2022; (66(6)):e0236621 doi:10.1128/aac.02366-21.
PMID: 35604210
This page is for informational purposes only and does not constitute medical advice. A healthcare professional should interpret your vulvovaginal candidiasis test results and evaluate persistent, recurrent, or severe symptoms.